Trials / Conditions / Lymphoma Receiving CAR-T Therapy
Lymphoma Receiving CAR-T Therapy
3 registered clinical trials studyying Lymphoma Receiving CAR-T Therapy — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogenei NCT07509450 | University Health Network, Toronto | N/A |
| Recruiting | Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B- NCT07284433 | AvenCell Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy NCT04107285 | Memorial Sloan Kettering Cancer Center | — |